The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...
A mum-of-three and breast cancer survivor is fighting for her life after being diagnosed with stage 3C ovarian cancer, less ...
During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic ...
Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...
Cancer remains a leading cause of death globally, with breast cancer being the most fatal for women. A recent American Cancer ...
10h
Inside Edition' reporter Alison Hall undergoes a double mastectomy, after discovering her breast cancer while on assignment.
The $30 million facility was made possible, in part, through a $4 million contribution through the AdventHealth Palm Coast ...
As supported by data from the phase 3 TROPION-Breast01 trial, datopotamab deruxtecan is now an FDA-approved treatment for ...
The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback